IGC — IGC Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapMomentum Trap

Annual balance sheet for IGC Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	9 M
Source:	10-K	10-K	10-K	10-K	10-KT
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	10.5	3.35	1.2	0.405	0.938
Net Total Accounts Receivable
Net Total Receivables	0.597	0.131	0.091	0.077	0.075
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	15.1	6.47	3.71	2.9	1.79
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9.87	8.54	3.89	3.32	2.15
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	26.8	17.2	9.9	8.75	9.71
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.44	1.9	2.34	2.26	2.16
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.94	2.27	2.58	2.42	2.29
Non Redeemable Preferred Stock
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	23.9	14.9	7.32	6.33	7.42
Total Liabilities & Shareholders' Equity	26.8	17.2	9.9	8.75	9.71
Total Common Shares Outstanding